Healthcare - Medical - Devices - NASDAQ - US
$ 11.24
0.988 %
$ 912 M
Market Cap
-18.43
P/E
BALANCE SHEET
811 M
ASSETS
590 M
LIABILITIES
174 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Bioventus Inc.
| Current Assets | 268 M |
| Cash & Short-Term Investments | 37 M |
| Receivables | 123 M |
| Other Current Assets | 108 M |
| Non-Current Assets | 543 M |
| Long-Term Investments | 0 |
| PP&E | 50 M |
| Other Non-Current Assets | 493 M |
| Current Liabilities | 175 M |
| Accounts Payable | 23 M |
| Short-Term Debt | 32.7 M |
| Other Current Liabilities | 120 M |
| Non-Current Liabilities | 414 M |
| Long-Term Debt | 378 M |
| Other Non-Current Liabilities | 36.7 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2015 | Dec-2014 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Cash & Cash Equivalents | 37.0 | 31.8 | 43.9 | 86.8 | 64.5 | 42.8 | 5.0 | 15.8 | ||||
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Receivables | 123.0 | 136.6 | 125.0 | 88.3 | 85.1 | 72.6 | 54.5 | 47.1 | ||||
| Inventory | 91.3 | 85.4 | 61.7 | 29.1 | 27.3 | 27.4 | 35.2 | 26.7 | ||||
| Other Current Assets | 33.3 | 21.1 | 32.4 | 7.6 | 6.1 | 5.6 | 4.8 | 5.7 | ||||
| Total Current Assets | 268.0 | 272.6 | 263.1 | 211.8 | 183.0 | 148.4 | 99.4 | 95.2 | ||||
| PP&E | 50.0 | 45.0 | 40.2 | 21.8 | 19.8 | 4.8 | 9.6 | 10.4 | ||||
| Intangible Assets | 482.4 | 1 038.7 | 695.2 | 191.7 | 216.5 | 237.0 | 319.2 | 274.3 | ||||
| Goodwill | 7.5 | 13.8 | 147.6 | 49.8 | 49.8 | 49.8 | 58.7 | 50.0 | ||||
| Long Term Investments | 0 | 2.6 | 29.3 | 19.4 | 3.3 | 2.8 | 0 | 0 | ||||
| Other Long Term Assets | 3.1 | (154.0) | 50.0 | 19.4 | 3.3 | 2.8 | 0.4 | 0.3 | ||||
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Total Assets | 810.9 | 1 372.6 | 1 225.9 | 494.5 | 472.4 | 442.7 | 487.4 | 430.4 | ||||
| LIABILITIES | ||||||||||||
| Accounts Payable | 23.0 | 36.7 | 16.9 | 4.4 | 6.4 | 8.2 | 8.4 | 5.4 | ||||
| Short Term Debt | 32.7 | 33.1 | 21.5 | 17.0 | 13.7 | 5.2 | 37.7 | 7.9 | ||||
| Other Current Liabilities | 115.0 | 231.7 | 134.3 | 98.8 | 66.4 | 49.9 | 39.0 | 37.6 | ||||
| Total Current Liabilities | 175.5 | 304.0 | 180.9 | 122.6 | 89.0 | 65.4 | 87.7 | 52.2 | ||||
| Long Term Debt | 377.6 | 399.4 | 354.7 | 187.5 | 202.5 | 189.6 | 158.8 | 163.1 | ||||
| Deferred Tax Income | 1.2 | 154.0 | 133.5 | 3.4 | 3.9 | 4.0 | 8.8 | 9.3 | ||||
| Other Liabilities | 35.5 | 257.0 | 23.0 | 36.9 | 6.2 | 5.4 | 39.7 | 28.3 | ||||
| Total Liabilities | 589.8 | 1 032.3 | 692.1 | 350.3 | 326.8 | 297.5 | 295.0 | 252.9 | ||||
| EQUITY | ||||||||||||
| Common Stock | 79 K | 78 K | 75 K | 285.2 | 285.1 | 285.2 | 113.4 | 113.4 | ||||
| Retained Earnings | (321.5) | (165.3) | (6.6) | (144.5) | (141.7) | (139.8) | (91.8) | (56.5) | ||||
| Other Accumulative Comprehensive Income/Loss | 0.8 | (0.1) | 0.2 | 1.6 | (0.5) | 65 K | (0.7) | 14 K | ||||
| Total Equity | 221.1 | 340.3 | 533.8 | 144.2 | 145.6 | 145.3 | 192.3 | 177.5 | ||||
| Total Liabilities and Equity | 810.9 | 1 372.6 | 1 225.9 | 494.5 | 472.4 | 442.7 | 487.4 | 430.4 | ||||
| SHARES OUTSTANDING | ||||||||||||
| Common Shares Outstanding | 62.6 | 61.4 | 59.5 | 56.8 | 56.8 | 55.6 | 56.8 | 56.8 | 55.6 | 55.6 | 55.6 | 0 |